
Retatrutide
A synthetic peptide also designated LY3437943, studied in laboratory assays involving GIP, GLP-1 and glucagon receptors.
Pricing to be announcedHM-RETATRUTIDE-10Exclusively for laboratory research. Not for human or animal use. Vial sizes are labeled quantities, not administration instructions.
About Retatrutide
Retatrutide is described in primary literature as a peptide with activity at three receptor families: GIP, GLP-1 and glucagon. Structural studies examine how the molecule interacts with each receptor. The description identifies the compound and its experimental context; it does not claim a health outcome or establish the identity or purity of an untested lot.
- Reference identity
- Synthetic peptide · LY3437943
- This selection
- 10mg · HM-RETATRUTIDE-10
Scientific references
References describe the named compound. They are not COAs or evidence of testing for a Horizon lot.
Primary literature · PubMed ↗Primary literature · PubMed ↗